STOCK TITAN

[SCHEDULE 13G/A] Maravai LifeSciences Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:07/29/2025
Maravai Lifesciences Holdings, Inc.

NASDAQ:MRVI

MRVI Rankings

MRVI Latest News

MRVI Latest SEC Filings

MRVI Stock Data

454.29M
108.71M
10.16%
90.18%
9.59%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO